Soo Kyoung Kim
Overview
Explore the profile of Soo Kyoung Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
74
Citations
501
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Domalaon K, Henderson L, Kim S, Leshikar H, Taylor S, Li Y, et al.
J Surg Orthop Adv
. 2024 May;
33(1):41-48.
PMID: 38815078
This study aims to describe the perception of need for same-sex and same-race mentorship and role models at evolving stages of a medical career and to explore whether these differences...
2.
Kang H, Kim J, Kim M, Kim J, Roh G, Kim S
Neurol Sci
. 2024 Mar;
45(8):3757-3766.
PMID: 38520638
Objective: Type 2 diabetes mellitus (T2DM) is a risk factor for cognitive impairment, and reduced heart rate variability (HRV) has been correlated with cognitive impairment in elderly individuals. This study...
3.
Su C, Kim S, Wang C, Kirsch D, Monjazeb A
Semin Radiat Oncol
. 2024 Mar;
34(2):243-257.
PMID: 38508788
Immunotherapy has shifted the treatment paradigm for many types of cancer. Unfortunately, the most commonly used immunotherapies, such as immune checkpoint inhibitors (ICI), have yielded limited benefit for most types...
4.
Wang C, Hunt J, Feinstein S, Kim S, Monjazeb A
Surg Oncol Clin N Am
. 2023 May;
32(3):617-629.
PMID: 37182996
Pre-clinical and clinical data clearly demonstrate the immune modulatory effects of radiotherapy (RT) but clinical trials testing RT + immunotherapy have been equivocal. An improved understanding of the immune modulatory...
5.
Kim S, Lee J, Lee J, Ahn J, Kim H
Health Promot Int
. 2022 Jul;
37(3).
PMID: 35788310
Smoking is a leading cause of diseases and death, with significant socioeconomic consequences. The purpose of this study was to evaluate the health and economic effectiveness of a workplace smoking...
6.
Kim K, Lee J, Shin H, Jeong E, Jang H, Ahn Y, et al.
Hepatology
. 2022 May;
77(3):888-901.
PMID: 35560370
Background And Aims: In obesity and type 2 diabetes mellitus, leptin promotes insulin resistance and contributes to the progression of NASH via activation of hepatic stellate cells (HSCs). However, the...
7.
Kim M, Kim H, Kim K, Kim S, Jung J, Hahm J, et al.
Diabetes Metab J
. 2022 Apr;
47(1):135-139.
PMID: 35487507
We compared the glycemic efficacy of treatment intensification between quadruple oral antidiabetic drug therapy and once-weekly glucagon-like peptide-1 receptor agonist (GLP-1RA)-based triple therapy in patients with poorly controlled type 2...
8.
Shin Y, Kim Y, Kim K, Baek J, Kim S, Jung J, et al.
Medicina (Kaunas)
. 2022 Jan;
58(1).
PMID: 35056361
Hypokalemic periodic paralysis (HPP) is a neuromuscular disorder associated with muscular dysfunction caused by hypokalemia. There are various causes of HPPs and rarely, HPP appears to be relevant to tenofovir...
9.
Kang H, Shin H, An H, Jin Z, Lee J, Lee J, et al.
Antioxidants (Basel)
. 2021 Nov;
10(11).
PMID: 34829528
Lipocalin-2 (LCN2) is an inflammatory protein with diverse functions in the brain. Although many studies have investigated the mechanism of LCN2 in brain injuries, the effect of LCN2 on amyloid-toxicity-related...
10.
Kim H, Kim Y, Lee C, Choi M, Chang H, Kim S, et al.
Diabetes Ther
. 2021 Sep;
12(11):2907-2920.
PMID: 34536208
Introduction: The aim of this study was to assess the efficacy and safety of switching to teneligliptin from other dipeptidyl peptidase-4 (DPP-4) inhibitors in patients with type 2 diabetes mellitus...